Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: VRDN) | Delayed: 22.43 -0.39 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.82 | 52 Week High | $ | |||
| Open | $22.61 | 52 Week Low | $ | |||
| Day High | $22.75 | P/E | N/A | |||
| Day Low | $22.33 | EPS | $ | |||
| Volume | 22,726 | |||||
